GKB Ophthalmics Ltd.

NSE: GKB BSE: 533212 SECTOR: Medical Equipment/Supplies/Accessories  5722   2   1

179.55
-9.45 (-5.00%)
BSE: Today, 05:10 PM

Price Summary

Today's High

₹ 193.95

Today's Low

₹ 179.55

52 Week High

₹ 197

52 Week Low

₹ 0

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

90.5 Cr.

Enterprise Value

100.83 Cr.

No. of Shares

0.5 Cr.

P/E

0

P/B

3.06

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  58.65

CASH

1.43 Cr.

DEBT

11.75 Cr.

Promoter Holding

59.09 %

EPS (TTM)

₹  -1.73

Sales Growth

26.73%

ROE

-7.31 %

ROCE

-2.24%

Profit Growth

-9.6 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year26.73%
3 Year-3.89%
5 Year-6.73%

Profit Growth

1 Year-9.6%
3 Year5.33%
5 Year-224.86%

ROE%

1 Year-7.31%
3 Year-8.65%
5 Year-8.91%

ROCE %

1 Year-2.24%
3 Year-3.54%
5 Year-3.86%

Debt/Equity

0.3866

Price to Cash Flow

38.84

Interest Cover Ratio

-0.728375645922265

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2022 59.09 0
Sep 2022 59.16 0
Jun 2022 59.73 0
Mar 2022 59.72 0
Dec 2021 59.69 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 3.9439188373249 days.
  • The company has a high promoter holding of 59.09%.

 Limitations

  • The company has shown a poor profit growth of 5.32780863389113% for the Past 3 years.
  • The company has shown a poor revenue growth of -3.89101912527277% for the Past 3 years.
  • Company has a poor ROE of -8.65386923993893% over the past 3 years.
  • Company has a poor ROCE of -3.53965252562802% over the past 3 years
  • Company has low Interest coverage ratio of -0.728375645922265.
  • Company has contingent liabilities of 19.2645 Cr.
  • The company has a low EBITDA margin of -2.65874196956168% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 42.0807.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
Net Sales 7.03 8.47 6.68 7.63 7.05
Total Expenditure 7.64 8 6.62 6.99 7.25
Operating Profit -0.61 0.47 0.06 0.64 -0.21
Other Income 0.53 1.15 0.16 0.11 0.03
Interest 0.32 0.31 0.37 0.34 0.41
Depreciation 0.64 0.62 0.62 0.35 0.32
Exceptional Items 0 0 0 0 0
Profit Before Tax -1.04 0.69 -0.78 0.05 -0.91
Tax 0.02 0.02 -0.04 -0.02 -0.02
Profit After Tax -1.05 0.68 -0.74 0.07 -0.89
Adjusted EPS (Rs) -2.09 1.35 -1.46 0.14 -1.76

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 36.92 30.47 25.56 21.34 27.05
Total Expenditure 37.9 31.52 26.29 21.92 27.49
Operating Profit -0.99 -1.05 -0.73 -0.57 -0.45
Other Income 1.05 2.62 1.38 3.34 1.96
Interest 1.23 1.39 1.35 1.34 1.34
Depreciation 1.58 3.43 3.47 2.99 2.49
Exceptional Items 0 0 0 -0.72 0
Profit Before Tax -2.74 -3.25 -4.17 -2.29 -2.31
Tax -0.17 -0.48 0 -0.18 0
Net Profit -2.58 -2.78 -4.17 -2.11 -2.31
Adjusted EPS (Rs.) -6.2 -5.99 -8.28 -4.18 -4.58

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 4.15 4.64 5.04 5.04 5.04
Total Reserves 22.78 30.03 30.21 27.73 25.36
Borrowings 0.02 0 0 1 1.62
Other N/C liabilities 1.62 4.93 4.97 5.72 5.69
Current liabilities 16.85 19.29 20.2 21.11 19.92
Total Liabilities 45.42 58.9 60.42 60.6 57.63
Assets
Net Block 16.98 24.29 24.83 22.28 21.27
Capital WIP 0.24 0 0 1.23 3.29
Intangible WIP 0 0 0 0 0
Investments 0.29 0.3 3.2 11.9 11.9
Loans & Advances 0.55 8.99 5.66 6.67 7.08
Other N/C Assets 0.06 0.05 0.09 0.04 0.03
Current Assets 27.3 25.26 26.65 18.48 14.06
Total Assets 45.42 58.9 60.42 60.6 57.63
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations -2.74 -3.25 -4.17 -2.29 -2.31
Adjustment 2.8 3.3 4.14 2.13 2.25
Changes in Assets & Liabilities -3.65 5.3 6.18 2.27 2.4
Tax Paid -0.12 -0.03 -0.01 0 -0.01
Operating Cash Flow -3.71 5.31 6.13 2.11 2.33
Investing Cash Flow 2.28 -8.63 -5.68 -11.52 -0.83
Financing Cash Flow 1.41 9.21 3.31 0.61 -1.5
Net Cash Flow -0.02 5.88 3.76 -8.8 0

Corporate Actions

Investors Details

PARTICULARS Dec 2021% Mar 2022% Jun 2022% Sep 2022% Dec 2022%
Promoters 59.69 59.72 59.73 59.16 59.09
krishna gopal gupta 17.24 17.24 17.24 17.24 17.24
vikram gupta 8.04 8.04 8.04 8.04 8.04
gaurav gupta 7.71 7.71 7.71 7.71 7.71
krishna murari gup... - - - - -
veena gupta 6.48 6.48 6.48 6.48 6.48
shefali chawla 5.22 5.22 5.22 5.22 5.22
krishnagopal gupta... - - - - -
krishnagopal gupta... - - - - 3.71
krishna gopal gupt... - 3.71 3.71 3.71 -
krishnagopal gupta... 3.83 - - - -
usha gupta . - - - - -
vivek gupta . - - - - -
aditya gupta . - - - - -
PARTICULARS Dec 2021% Mar 2022% Jun 2022% Sep 2022% Dec 2022%
Investors 40.31 40.28 40.27 40.84 40.91
krishna murari gup... 7.07 7.07 7.07 7.07 7.07
brijendra kumar gu... 5.28 5.28 5.28 5.28 3.43
somo vision co. lt... - - - - -
usha gupta - - - - 2.47
usha gupta . 2.47 2.47 2.47 2.47 -
raviraj developers... - - - - -
polus global fund 2.15 2.15 2.15 2.15 -
polus global fund - - - - 2.15
uma gupta - - - - 1.72
dhwaja commodity s... - - - - -
dhwaja commodity s... 1.56 - 1.56 1.56 1.56
jm financial servi... 1.73 1.51 1.51 1.50 -
sanjiv kumar gupta 1.52 1.52 1.52 1.52 1.52
dhwaja commodity s... - 1.56 - - -
lalit kumar gupta 1.52 1.52 1.52 1.52 -
new millenium tech... 1.19 - 1.19 1.19 1.21
new millenium tech... - 1.19 - - -
jyotivardhan jaipu... 1.44 1.44 1.44 1.44 1.44
raj kumar agarwal 1.44 1.44 1.44 1.44 1.44
rajiv jhunjhunwala 1.44 1.44 1.44 1.44 1.44
bma wealth creator... - - - 1.13 -
bma wealth creator... - 1.15 1.15 - 1.22
hartmut t wurster 1.10 - - - -
prabha mohta 1.08 1.08 1.08 1.08 1.08
chetan gopaldas ch... 1.06 1.06 1.06 1.06 -
chetan g cholera - - - - 1.06
rajasthan global s... - - - - -
llp - - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

GKB Ophthalmics informs about disclosure of related party transactions26 Nov 2022, 2:38PM GKB Ophthalmics informs about newspaper cuttings16 Aug 2022, 5:05PM GKB Ophthalmics informs about board meeting28 Jul 2022, 4:27PM GKB Ophthalmics informs about disclosure14 Jun 2022, 4:12PM Gkb Ophthalmics informs about disclosure17 May 2022, 4:48PM Gkb Ophthalmics informs about outcome of director’s meeting17 Mar 2022, 5:14PM Gkb Ophthalmics informs about postal ballot notice11 Mar 2022, 4:38PM GKB Ophthalmics informs about related party transactions8 Dec 2021, 11:53AM GKB Ophthalmics informs about disclosure6 Sep 2021, 4:01PM GKB Ophthalmics informs about book closure6 Sep 2021, 3:59PM GKB Ophthalmics informs about disclosure31 Aug 2021, 2:25PM GKB Ophthalmics informs about newspaper publication30 Aug 2021, 1:47PM GKB Ophthalmics informs about prohibition of insider trading30 Aug 2021, 1:41PM GKB Ophthalmics informs about newspaper cuttings14 Jun 2021, 4:34PM GKB Ophthalmics informs about disclosure11 Mar 2021, 3:53PM GKB Ophthalmics informs about disclosure9 Mar 2021, 4:24PM GKB Ophthalmics informs about disclosure8 Mar 2021, 12:11PM GKB Ophthalmics informs about disclosure25 Feb 2021, 3:03PM GKB Ophthalmics informs about disclosure19 Feb 2021, 12:55PM GKB Ophthalmics informs about newspaper publication1 Feb 2021, 10:49AM GKB Ophthalmics informs about disclosure1 Jan 2021, 3:57PM GKB Ophthalmics informs about disclosure17 Dec 2020, 3:30PM GKB Ophthalmics informs about outcome of board meeting16 Dec 2020, 2:15PM GKB Ophthalmics informs about postal ballot notice30 Nov 2020, 3:10PM GKB Ophthalmics informs about proceedings of the 38th AGM26 Sep 2020, 2:08PM GKB Ophthalmics informs about company updates7 Sep 2020, 3:19PM GKB Ophthalmics informs about newspaper cuttings11 Aug 2020, 10:19AM GKB Ophthalmics informs about prohibition of insider trading17 Jul 2020, 3:36PM GKB Ophthalmics informs about newspaper publication12 Jun 2020, 3:41PM

GKB Ophthalmics Stock Price Analysis and Quick Research Report. Is GKB Ophthalmics an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into GKB Ophthalmics and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 2.3304 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. GKB Ophthalmics has a Debt to Equity ratio of 0.3866 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In GKB Ophthalmics , the EPS growth was -9.60352001530442 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, GKB Ophthalmics has OPM of -1.65075679712513 % which is a bad sign for profitability.
     
  • ROE: GKB Ophthalmics have a poor ROE of -7.31401544291535 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about GKB Ophthalmics

X